Gene Therapy For Sickle Cell Disease Passes Key Preclinical Test

13 May 2018

A precision-engineered gene therapy virus, inserted into blood stem cells that are then transplanted, markedly reduced sickle-induced red-cell damage in mice with sickle cell disease, researchers from Dana-Farber/Boston Children’s Cancer and Blood Disorders Center report today in the Journal of Clinical Investigation.

Leave a Reply

Your email address will not be published. Required fields are marked *